Research reveals undertreatment of women with heart disease

Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).

Biogen to halt sales and development of controversial Alzheimer’s drug Aduhelm

Biogen will stop sales and development of its controversial Alzheimer’s drug Aduhelm, walking away from a drug that was approved against outside experts’ advice, led

February 1, 2024

COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says

The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently circulating SARS-CoV-2 variants, including KP.3.1.1 and LB.1. “Based

September 28, 2024

Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 – Biotech Investments

EQS-News: PharmaSGP Holding SE / Key word(s): Personnel CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 05.11.2024

November 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.